Stocktoria
PALISADE BIO, INC. PALI
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2006-12-20
PALISADE BIO, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $300,000 | $0 | — | $13,520 | $15,394 | $260,000 | $260,000 | $16,246 |
| R&D expense | — | $16.0M | — | — | — | $2.0M | $4.1M | $4.0M | $8.1M | $13.2M |
| Operating income | -$18.1M | -$14.9M | -$13.1M | -$15.7M | -$41.9M | -$9.3M | -$8.6M | -$8.3M | -$13.3M | -$20.6M |
| Interest expense | — | $12,000 | $15,000 | $13,000 | $2.4M | $235,000 | $8,920 | $7,698 | $159,066 | $1.1M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $1,000 | — | — | — | $0 |
| Net income | -$16.8M | -$14.4M | -$12.3M | -$14.3M | -$26.6M | -$10.3M | -$8.4M | -$4.9M | -$15.7M | -$21.1M |
| EPS (diluted) | $-0.30 | $-10.19 | $-27.01 | $-16.53 | $-169.74 | $-3.72 | — | — | — | — |
| Operating cash flow | -$10.8M | -$12.2M | -$11.1M | -$13.4M | -$14.8M | -$4.8M | -$7.3M | -$7.7M | -$13.4M | -$15.6M |
| Free cash flow | — | -$12.2M | -$11.1M | -$13.4M | -$14.8M | -$4.8M | — | -$7.7M | -$13.4M | -$15.7M |
| Cash & equivalents | $133.4M | $9.8M | $12.4M | $12.4M | $10.5M | $713,000 | $5.1M | $5.8M | $6.7M | $15.2M |
| Total assets | $134.3M | $10.9M | $14.1M | $15.8M | $12.5M | $3.0M | $6.6M | $7.7M | $13.9M | $22.6M |
| Total liabilities | $5.0M | $3.4M | $2.7M | $3.3M | $5.1M | $10.1M | $1.5M | $1.6M | $5.4M | $11.3M |
| Shareholders' equity | $129.4M | $7.5M | $11.3M | $12.5M | $7.4M | -$16.6M | -$8.3M | $6.0M | $8.5M | $11.3M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | -100.0% | — | — | — | -12.2% | -94.1% | +0.0% | +1500.4% | +56.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.